Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Payne

Showing results (1-10 of 174) with videos related to

Pageof 18
Sort By:
Health Economics|October 13, 2009
Fish and chips all round? Regulation of DNA-based genetic diagnosticsKatherine Payne
Pharmacogenomics|December 25, 2007
Towards an economic evidence base for pharmacogenetics: consideration of outcomes is keyKatherine Payne
Pharmacoeconomics|May 17, 2011
The appropriate elicitation of expert opinion in economic models: making expert data fit for purposeWilliam Sullivan, Katherine Payne
Personalized Medicine|May 23, 2018
Removing barriers to a clinical pharmacogenetics serviceWilliam Newman, Katherine Payne
European Journal of Medical Genetics|December 18, 2018
Measuring the economic value of genetic counsellingKatherine Payne, Martin Eden
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 4, 2014
Utility Values for Adults with Unipolar Depression: Systematic Review and Meta-AnalysisSyed Mohiuddin, Katherine Payne
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2013
Reflections on market access for personalized medicine: recommendations for EuropeKatherine Payne, Lieven Annemans
Handbook of Experimental Pharmacology|June 29, 2022
Economics and Precision MedicineKatherine Payne, Sean P Gavan
Pharmacoeconomics|May 25, 2017
Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?Caroline M Vass, Katherine Payne
Pharmacogenomics|April 27, 2010
Cost-effectiveness analysis in pharmacogenomicsKatherine Payne, Fatiha H Shabaruddin
Pageof 18

Showing results (1-10 of 174) with videos related to

Sort By:
Pageof 18
Health Economics|October 13, 2009
Fish and chips all round? Regulation of DNA-based genetic diagnosticsKatherine Payne
Pharmacogenomics|December 25, 2007
Towards an economic evidence base for pharmacogenetics: consideration of outcomes is keyKatherine Payne
Pharmacoeconomics|May 17, 2011
The appropriate elicitation of expert opinion in economic models: making expert data fit for purposeWilliam Sullivan, Katherine Payne
Personalized Medicine|May 23, 2018
Removing barriers to a clinical pharmacogenetics serviceWilliam Newman, Katherine Payne
European Journal of Medical Genetics|December 18, 2018
Measuring the economic value of genetic counsellingKatherine Payne, Martin Eden
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 4, 2014
Utility Values for Adults with Unipolar Depression: Systematic Review and Meta-AnalysisSyed Mohiuddin, Katherine Payne
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2013
Reflections on market access for personalized medicine: recommendations for EuropeKatherine Payne, Lieven Annemans
Handbook of Experimental Pharmacology|June 29, 2022
Economics and Precision MedicineKatherine Payne, Sean P Gavan
Pharmacoeconomics|May 25, 2017
Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?Caroline M Vass, Katherine Payne
Pharmacogenomics|April 27, 2010
Cost-effectiveness analysis in pharmacogenomicsKatherine Payne, Fatiha H Shabaruddin
Pageof 18